The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...

Eligible people in the Black Country are being reminded to come forward for the respiratory syncytial virus (RSV) vaccine.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The flu just won’t quit this year. The virus seemed to peak after the December holidays in Massachusetts, headed back down, ...

RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

It may be Valentine's Day, but before you cuddle up with your loved one, don't forget that we are in the middle of cold and ...

Among the handful of drugmakers to advance a successful COVID-19 vaccine in 2020, Moderna—whose mRNA shot Spikevax was also ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...

Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.

In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...

Dr. Smith is the president of the Tennessee Chapter of the American Academy of Pediatrics.